Application
Western blot analysis of extracts from COS7 cells treated with Serum using Phospho-CD19 (Tyr531) Antibody. The lane on the right is treated with the antigen-specific peptide.| Product Name | CD19 (phospho Tyr531) Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19, CD19 molecule, MGC12802 |
| Product description | Receptor for the MIP-3-beta chemokine. Probable mediator of EBV effects on B-lymphocytes or of normal lymphocyte functions.1) Ishiura N, et al. (2010)Eur J Immunol 40, 1192-204. Browne CD, et al. (2009) Immunity 31, 749-60. Aiba Y, et al. (2008)Blood 111, 1497-503. |
| Immunogen | CD19 (phospho Tyr531) antibody was raised against a peptide sequence around phosphorylation site of tyrosine 531 (D-S-Y (p)-E-N) derived from Human CD19. |
| Modification | Phosphoralated |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| Western Blot: 1:500~1:1000: |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | CD19 |
|---|---|
| Alternative Names | B-lymphocyte antigen CD19 B-lymphocyte surface antigen B4 CD19 CD19 molecule MGC12802 |
| Molecular Weight(MW) | 61 kDa |
| Tissue Specificity | The antibody detects endogenous level of CD19 only when phosphorylated at tyrosine 531. |
| Entrez Gene | 930 |
|---|---|
| Protein Accession | NP_001171569.1 |
Application
Western blot analysis of extracts from COS7 cells treated with Serum using Phospho-CD19 (Tyr531) Antibody. The lane on the right is treated with the antigen-specific peptide.| Application Notes | Western Blot: 1:500~1:1000: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store antibody at -20˚C for up to one year. |
| Storage Buffer | Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Data sheet for OM274137